Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

VERSTOVSEK, SRDAN

One or more keywords matched the following items that are connected to VERSTOVSEK, SRDAN

Item Type	Name
Concept	Interferon-alpha
Academic Article	Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.
Academic Article	Interferon alpha therapy for patients with essential thrombocythemia: final results of a phase II study initiated in 1986.
Academic Article	Experience with oral interferon-alpha in patients with essential thrombocythemia and polycythemia vera.
Academic Article	PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study.
Academic Article	Experimental therapeutics for patients with myeloproliferative neoplasias.
Academic Article	Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
Academic Article	Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Academic Article	Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
Academic Article	Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha.
Academic Article	Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disorders.
Academic Article	Is there still a role for interferon-alpha for newly diagnosed chronic myeloid leukemia in chronic phase?
Academic Article	Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemia.
Academic Article	Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon a-2a.
Academic Article	Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis.
Academic Article	Survival advantage with imatinib mesylate therapy in chronic-phase chronic myelogenous ;eukemia (CML-CP) after IFN-alpha failure and in late CML-CP, comparison with historical controls.
Academic Article	Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience.
Academic Article	Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.
Academic Article	Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factor.
Academic Article	Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha.
Academic Article	Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.
Academic Article	Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Academic Article	Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.
Academic Article	Therapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea.
Academic Article	New Therapeutic Approaches in Polycythemia Vera.
Academic Article	Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
Academic Article	Immunotherapy based approaches in myelofibrosis.
Academic Article	Novel treatment strategies for myeloproliferative neoplasms.
Academic Article	Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study.
Academic Article	Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia.
Academic Article	Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera.

Search Criteria

Interferon alpha